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Introduction
Mutagenicity testing is beginning to find
a place as a factor in evaluation of the safety
of compounds to which the human popula-
tion is exposed. The mutation systems select-
ed for such tests should ideally involve in
vivo studies with mammals and encompass
scoring of a broad spectrum of mutational
events including both transmissible chromo-
some aberrations and point mutations. The
frequency of chromosome aberrations ob-
tained after a certain treatment can be as-
sessed quantitatively without prohibitive
costs and effort. At the present time there
is only one proven system which can be used
to screen for specific locus mutations in
mammals in vivo; the seven specific locus
system of Russell. On the other hand there
are many microbial systems in which point
mutation frequencies can be easily deter-
mined quantitatively. It is a known fact,
however, that mammals can convert non-
mutagenic compounds (promutagens) to
highly mutagenic metabolites and that these
promutagens are not mutagenic in micro-
organisms (1). In order to combine the drug
metabolism of the mammal with the excell-
ence of the microbial systems for measuring
point mutations, the host-mediated assay
(1) and the microsomal system (2) were
developed. In the host-mediated assay the
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indicator organism is injected into the
animal by one route and the promutagen or
mutagen is administered preferably by a
different route. The indicator organism is
then later recovered and the induced muta-
tion frequency is scored among the recover-
ed cells. In the microsomal system the in-
dicator organism is mixed directly into the
reaction mixture containing microsomes, co-
factors, and the drug. After a certain reac-
tion time the cells are recovered again and
screened for presence of mutants.
Dimethylnitrosamine (DMN) and diethyl-
nitrosamine (DEN) are two chemicals
which are nonmutagenic by themselves but
which are converted to mutagenic substances
by hydroxylation (3). DMN is converted to
a highly mutagenic compound in the host-
mediated assay (1) or in the microsomal
system (2). Both DMN and DEN are potent
tissue-specific carcinogens in many animal
species. The tumorigenic activity of these
compounds seems somewhat related to the
presence of the activation enzymes (4-6).
We felt, therefore, that it was important to
correlate the activity of demethylase with
the formation of mutagenic metabolites from
DMN. The various laboratory test animals
respond with great differences to the car-
cinogenic activity of chemicals. So the choice
of test animal for evaluating the carcinogen-
ic activity of a compound is very impor-
tant. For similar reasons, we felt that it
was important initially to evaluate the
ability of various laboratory animal strains
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metabolites both in the host-mediated assay
and the microsomal system.
By comparison of the results obtained in
the various activation systems and with dif-
ferent indicator organisms, we have attempt-
ed to evaluate the relative degree of sensi-
tivity of these systems. As 'genetic point
mutation indicators, we have used the induc-
tion of ad-3 forward mutations in Neuro-
spora crassa and the induction of histidine
reversions in the histidine-requiring strain
G46, of Salmonella typhimurium.
The Microsomal System
Preparation of the Microsomes
Sterile technique, sterile glassware, and
sterile solutions were used during the prep-
aration of the liver microsomes. The ani-
mals were killed by decapitation and bled
thoroughly before removal of the liver. After
the livers were secured, they were rinsed
three times in buffer. Livers from three
animals were pooled for each assay. The
livers were then homogenized in buffer con-
taining sucrose with a Teflon pistol in a glass
tube. The crude microsome preparation was
obtained as the supernatant after centri-
fugation of the liver homogenate at 20,000g
for 20 min. This is what we have defined
in the text as the 20,000g supernatant. In
order to obtain the purified microsomes,
we followed the technique described by Kup-
fer and Levin (7). The following gives a
short description of that technique. The
livers were prepared and homogenized in
the same manner as described above. The
homogenate was centrifuged at 10,000g for
20 min in order to remove cellular fragments.
The supernatant was decanted into a solution
containing Mg++ and Ca++. In this solution
the microsomes aggregated and they were
pelleted by centrifugation at 150Og for 10
min. The pellet was washed once by suspend-
ing it in sucrose and recentrifuging, and
it was then resuspended in 1.15%o KCl for
use. This is what we have defined as the puri-
fied microsomes in the text. Microsomal pro-
tein was measured accoding to the technique
of Lowry (8). Microsomes prepared this way
correlate well in enzyme content and enzyme
reaction with the microsomes pelleted by
centrifugation at 100,000g (7, 9).
Individual Components of the Reaction
Mixture
The microsomal reaction mixture is com-
plex. In order to investigate the importance
of each component, the formation of muta-
genic metabolites was measured in mix-
tures from which the components were de-
leted one at a time. Table 1 indicates clearly
that they are all necessary. In the case in
which N2 was used instead of O2, there was
no mutagenesis indicating that the forma-
tion of the active metabolites was an oxida-
tion process. It was also clear that the for-
mation of the mutagenic metabolites re-
quired NADPH which indicated that the
activation of DMN was enzymatic. Only in
the case where MgCL2 was omitted was there
any residual activity, probably due to the
fact that the micromomes already contained
a certain amount of Mg+.
Microsomal Inhibitors
SKF 525-A is a well-known general micro-
some inhibitor (10). Its ability to stop the
formation of mutagenic metabolites was
tested on the 20,000g supernatant from
homogenized livers of male mice (B6D2F1).
Table 1. Effects of treatment conditions on the
frequency of histidine reversion induced in
S. typhimurium strain TA1530.t
Reversions
Survival, Number of per 106
Treatment % revertants survivors
Complete system 114 916 8.16
Complete system 95 2 0.02
plus N2minus 02
Minus NADPH 121 1 0.01
Minus microsomal 126 0 0
fraction
Minus MgCl2 109 20 0.19
Minus DMN 100 0 0
(control)
a The preparation of the microsomal fraction was
as described by Malling (2).
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promutagen in the normal microsome reac-
tion mixture, 38 revertants per 106 survivors
were induced in G-46. Upon supplement-
ing the reaction mixture with SKF 525-A
to a final concentration of 1mM, no increase
in the reverse mutation frequency over the
control was found, indicating a complete in-
hibition of the DMN activating enzymes in
the microsomes. The same system supple-
mented with SKF 525-A to give a final con-
centration of O.1mM had only 3%o of the
normal mutagenic activity. The experiment
confirmed that the formation of the muta-
genic metabolites is due to microsomal
enzymatic conversion of DMN.
Products of the Metabolism of
Aliphatic Nitrosaminas
The first step in the metabolic activation
of aliphatic nitrosamines is probably hydro-
xylation of the carbon next to the nitrogen.
The subsequent steps may be spontaneous re-
sulting in formation of a carbonium radical
and an aldehyde (11). In the case of DMN
the aldehyde is formaldehyde. This is the
product which was determined during en-
zyme activity studies.
Mutagenicity of Formaldehyde
Although formaldehyde is generally con-
sidered to be the nonactive metabolite of
DMN, it has nevertheless been shown to
be a weak mutagen in several organisms
(12, 13). It is, therefore, important to esti-
mate the maximal contribution of formalde-
hyde to the induced mutation frequency. The
mutagenicity of formaldehyde was measured
in the microsomal system by use of purified
microsomes and formaldehyde as the muta-
gen. The amount of formaldehyde which is
converted depends on the reaction condi-
tions; after 15 min reaction time and with
a concentration of O.1M DMN, approximate-
ly 1 o of the DMN was converted. In order
to maximize the conditions for induction of
mutations with formaldehyde, it was used
in a concentration equal to the maximum
experimental conversion of DMN (0.2 /Lmole
ml formaldehyde) Salmonella typhimurium
G46 was used as-the indicator organism in
which histidine -revertants were scored as
mutations. Under these conditions formalde-
hyde did not give-a significant increase over
control in reversion frequency.
Kinetics
Table 2 shows the reverse mutation fre-
quency of G46 obtained upon treatment with
DMN using various concentrations of the
20,000g supernatant in the reaction mix-
ture. It is clear from Table 2 that there is
no direct proportionality between the amount
of supernatant and the reverse mutation
frequency.
By working with a pure microsome prep-
aration, we can simultaneously measure
the reverse mutation frequency in one assay
and the activity of microsomal demethylase
by the formation of formaldehyde. Figure 1
shows the frequency of reverse mutations in
G46 after DMN treatment using various
amounts of purified microsome in the reac-
tion mixture. The data presented on this
Figure 1 are in good agreement with the
data presented in Table 2 obtained with the
20,000g supernatant. Figure 2 shows the
correlation between reverse mutation fre-
quencies and the formaldehyde production.
Table 2. Mutagenicity of DMN in relation to amount
of enzyme.'
Amount of Reversions
liver per 106
Treatment (wet), mg survivors
Control 100 0.06
100 119.0
50 40.0
25 2.0
DMN (100mM) 12.5 0.13
6.25 0.12
3 0.05
a Livers from three male adult B6D2F1 mice were
homogenized in pH 7.5 buffer containing 0.0125M
MgCl and 0.25M sucrose, and centrifuged at 20,000g.
The supernatant was serially diluted and added to
a reaction mixture containing Salmonella typhi-
murium, 4 mg TPNH, and 100 mM DMN and
incubated 20 min at 370C under 02. 100% of the
treated bacteria survived.
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certain amount of metabolism was there a
linear increase in the reverse mutation fre-
quency. It appeared that the active metabo-
lite has to reach a critical concentration or
critical total amount before a large number
of mutations are induced. After this point
was reached, the reverse mutation frequency
increased proportionally with the increas-
ing production of formaldehyde. This ap-
parent "threshold" could be due to (a) the
presence of a certain number of reactive
groups in the reaction mixture which had
to be saturated by the active metabolites
before any appreciable amount was left over
for induction of mutations, (b) a concen-
tration effect on transport across the bacte-
rial cell wall, or (c) certain unique charac-
teristics of the reverse mutation sites in
strain G46.
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FIGURE 1. Effect of concentration of microsomal
protein on the metabolism of DMN to a mutagen.
Microsomes were prepared by the calcium pre-
cipitation technique from DBA 2/J male mouse
livers and added in appropriate amounts to a
15-min incubation containing 1.6 mg TPNH/ml,
lOOmM DMN, pH 7.5 buffer, and Salmonella
typhimurium His G46.
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FIGURE 2. Correlation of DMN demethylase activity
and metabolism of DMN to a mutagen at varying
microsomal protein concentrations. Livers from
three male . DBA 2/J mice were pooled, and
microsomes were prepared by the calcium pre-
cipitation technique. Varying quantities of protein
were incubated in identical manner for bacterial
mutagenesis and DMN demethylase activity (for-
maldehyde production). The 15-min incubations
contained lOOmM DMN, 1.6 mg/ml TPNH, pH
7.5 buffer, and either water or Salmonella in 0.9%
saline.
Enzyme Induction
The drug-metabolizing enzymes of the
liver can be increased by administering cer-
tain compounds to the animal. Phenobar-
bital and 3-methylcholanthrene (3-MC) are
some of the generally used inducers of drug-
metabolizing enzymes. Table 3 gives the re-
verse mutation frequency in strain G46
after treatment with DMN in the micro-
somal system with the 20,000g supernatant.
Some of the animals had been pretreated
with phenobarbital or 3-MC by intraperi-
toncal (IP) injections or by prefeeding
with butylated hydroxytoluene (BHT). It
is clear from these data that pretreatment
with all three inducers resulted in an in-
crease in the mutagenic activity of the micro-
somal system with both DMN and DEN.
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74Table 3. Effect of enzyme induction of the ability of mouse
DEN and DMN to mutagens.a
liver to metabolize
Mutagen Revisions per 10 6 survivors
Inducer Strain of mice Type Concn, mM Noninduced Induced
Phenobarbital B6D2F1 DMN 180 177 378
Control 0.03 0.04
3-MC B6D2F1 DMN 180 129 152
Control 0.02 0.03
BHT 101;C3F1 DMN 45 27 62
Control 0 0.01
Phenobarbital B6D2F1 DEN 200 0.53 0.93
Control 0.03 0.04
3-MC B6D2F1 DEN 200 0.34 0.57
Control 0.02 0.03
BHT 101 ;C3F1 DEN 45 0.13 0.32
Control 0.05 0.05
aLivers from at least three male mice were pooled to obtain each mutant frequency. The 20,000g super-
natant of the liver homogenate (2 ml solution/liver) was incubated with 4 mg TPNH, Salmonella typhi-
mur.um, and DMN or DEN for 20 min. Sodium phenobarbital was given IP, b.i.d., doses of 80/mg/kg-day
for 3 days, the last injection 12 hr prior to sacrifice. Age-matched controls were given corresponding
injections of saline. 3-Methylcholanthrene, 0.5 mg in 0.5 ml olive oil, was injected IP 24 hr prior to sacri-
fiee; age-matched controls received 0.5 ml olive oil. BHT was fed to animals as 0.75% of diet for 14 days.
ad-3 Mutation System in Neurospora crassa,
This mutation system is based on detec-
tion of forward-mutations in two adenine
genes, ad-3A and ad-3B (14). Mutants in
the two genes block the purine biosynthesis
in two sequential steps, and lead to accumu-
lation of purple pigments in the mycelium.
The mutants are detected as purple colonies
among white nonmutated colonies. The col-
onies are grown submersed, and it is easy
to screen 50 x 106 colonies in a day. Neuro-
spora is normally haploid but forms hetero-
karyons. A heterokaryon heterozygotic for
the two adenine-genes, ad-3A and ad-3B, is
white. The heterokaryons mimic the diploid
cells in many ways. Purple ad-3 mutations
induced in such a heterokaryon can be point
mutations in either of the two genes or
deletion of either one or both of the genes.
The ad-3B mutants can either be non-
complementing or have a polarized or non-
polarized complementation pattern. The ad-
3.A mutants do not show complementation.
Work with the reverse mutation frequen-
cies in various mutants induced by a series
of specific chemical mutagens and with the
complementation response of the mutant
shown that there are many different muta-
tional sites in both loci (15-17).
From growth studies it is known that the
mutants recovered in de Serres' forward
mutations system ranged from mutants
totally dependent on adenine to mutants
which can grow with wild-type rate on
minimal medium (18). We can, therefore,
conclude that in this system a broad spec-
trum of mutational damage can be detected.
It has previously been established that
DMN and DEN do not induce mutations
in directly treated Neurospora conidia.
However, in a chemical system which mimics
the liver metabolism of these two compounds
(3), both DMN and DEN are mutagenic.
Thus, the active metabolites of DMN and
DEN are mutagenic in Neurospora.
The Salmonella typhimurium His G46
Locus
Salmonella normally do not require histi-
dine to grow. However, Ames (19) has iso-
December 1973 75Table 4. Induction of ad-S mutations in Neurospora
and histidine reversion in S. typhimurium (G46) in
the host-mediated assay after treatment of the
mice with DMN.
DMN, Mutations per
Organism mg/kg 106 survivors
Neurospora 100 0
Salmonella His G46 100 1.94
Neurospora many mutational sites on two
genes are being screened. Two possible ex-
planations are: (a) the active metabolic pro-
duct of DMN may not penetrate as well into
Neurospora as into Salmonella or (b) the
particular mutational site in G46 may rep-
resent a "hot spot" for the particular type
-. of alkylation produced by the active meta-
-. bolite of DMN.
lated a number of mutant strains which-C---Comparison of Host-Mediated Assay
require histidine. Strain G46 is such a mutant .-and Microsomal Assay
a :1.. 1- 4,. s 4. 1 I " 1: strain, ancu 1T can De reverteu to n1isilne.-
independence by a base-pair substitution.
Thus, detection of mutagenicity using this
single strain is restricted to a limited num-
ber of sites in the DNA, in which changes
result in a reverse mutation.
Comparison of Indicator Organisms
Table 4 shows the frequency of ad-3 mu-
tations obtained among Neurospora conidia
injected into the peritoneal cavity of mice
when the mice were treated with DMN and
the frequency of histidine revertants induced
in S. typhimurium G46 under similar condi-
tions.
It is clear that the reversion sites in G46
are much more sensitive than the a-3 loci
of Neurospora. This is a surprising result,
since in G46 the mutations induced in a few
codons are being measured, whereas in
Table 5 shows the results obtained in an
host-mediated assay with the use of Neu-
rospora as the indicator organism and
treatment of the animal with either DMN
or DEN. Several routes of administration
were used; the conidia were injected either
IP or into the tail vein (IV). With IV in-
jection a portion of the conidia are trapped
in the liver and lungs of the animal. Biop-
sies have shown the conidia well dispersed.
Upon assay of the promutagen DEN, no
effect was found when the Neurospora were
injected IP, and a slight increase in muta-
tion frequency over control was observed in
conidia injected IV and recovered from the
liver. Similarly, DMN did not increase
the mutation frequency of IP conidia above
the control and in Neurospora injected IV
and isolated from the liver, DMN increased
the mutant frequency dramatically.
Table 5. Effect of route of administration of conidia and DMN or DEN on mutation
induction in Neurospora conidia in the host-mediated assay.
Pro- Route of administration
mutagen Number of Mutations
dose, Conidia Chemical ad-S per 10'
Experiment Treatment mg/kg or saline mutations survivors
12-187 In vitro control 0 - 0 0
DEN, in mice 200 IP IM 1 0.31
12-195 In mice, liver 0 IV IP 5 0.65
DEN, in mice, liver 150 IV IP 14 1.74
12-187 In vitro, control, 370C 0 - 0 0
Control, mice 0 IP IM 0 0
DMN, mice 100 IP IM 1 0.40
12-201 In vitro, control, .37'C 0 - 0 0
Control, mice, liver 0 IV IM 0 0
DMN, mice, liver 75 IV IM 528 286
Environmental Health Perspectives 76An explanation of these results must take -bo-lites is clearly demonstrated in the next
into account both anatomy and metabolism. series of experiments. In the mouse micro-
We suggest that the highly reactive meta- some system, under the same conditions un-
bolites of DMN and DEN are extremely der-which DMN induced 100-200 revertants
short-lived and cannot easily survive trahs-- per- 106 survivors in bacteria, only 5 ad-3
port from the liver, where the metabolites mutations per 106 survivors were found in
are primarily formed, to the peritoneum. -Neurospora (Ong, personal communica-
However, when the conidia are sitting in tion). In Neurospora conidia injected IV and
the liver, they may easily come into close recovered from the liver, the ad-3 mutation
contact with the active metabolites. frequency is 250 per 106 survivors.
It is difficult to make comparisons of data In summary of this discussion of alter-
obtained from the host-mediated assay with native assay methods, we are looking for
that obtained from microsomal mutagenesis a mutagenesis assay which is the most sen-
assays. In the host-mediated assay, the sur- sitive in the detection of mammalian meta-
vival of the host is the determining factor bolism of a promutagen to mutagenic but
for maximum dose; in the microsomal sys- labile products. The Salmonella G46 data
tem some efficiency of metabolism may be indicate that an in vitro microsomal system
lost. However, the magnitude of the differ- is -more sensitive than the intraperitoneal
ences does allow for some comparison of the host-mediated assay, and the Neurospora
assay techniques in terms of their useful- data indicate that the intrahepatic host-
ness in screening for promutagens. mediated assay is even more sensitive than
The mouse host-mediated assay with G46 the microsomal assay.
with 3 hr of IP incubation and a dose of
100 mg/kg DMN (equal to a concentration Species and Strain Differences
of 1.3 mM DMN in the mouse assuming equal Rat d Mi-
tissue distribution) induced 1.94 reversions
per 106 surviving bacteria. In the mouse Table 6 gives the results of using DEN
microsome system, 30 min of incubation and DMN in the liver microsome system
with 180 mM DMN induced 200 reversions when the microsomes were obtained from
per 106 survivors (100% survival). The data either mice or rats. In general, there is good
indicate that the peritoneal cavity is a very agreement between the in vitro system and
ineffective place to measure labile mutagenic the host-mediated assay; DEN does not
metabolites formed in the liver. The same show very high mutagenic activity in either
conclusion was reached above when the mu- system (Table 7). One surprising result is
tagenicity of DMN in Neurospora conidia that, in comparison with the results from
in intraperitoneal and intrahepatic (IH) the host-mediated assay, DMN did not show
locations were compared. a very high mutagenicity in the rat liver
Nevertheless, the inefficiency of using the microsome system. A possible explanation
microsomal system to form mutagenic meta- for that is that in the host-mediated system,
Table 6. Induction of histidine reversions in G46 (S. typhimurium) in the microsomal system (from liver).
Reversions
Promutagen, Number of per 106
Animal Treatment mM revertants survivors
Rat Control 0 11 0.06
Rat DEN 45 8 0.05
Rat DMN 45 20 0.11
Mouse Control 0 9 0.06
Mouse DEN 45 51 0.31
Mouse DMN 45 1042 6.2
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Number Reversions
Experi- Promutagen, of per 10'
ment Species Treatment mg/kg revertants survivors
27-112 Rat Control 0 7 0.02
Rat DMN 200 193 1.01
27-116 Mouse Control 0 0 0
Mouse DMN 25 2153 0.58
Mouse DMN 200 2527 1.41
27-118 Rat Control 0 4 0.0037
Rat DEN 400 8 0.0068
27-119 Mouse Control 0 3 0.0012
Mouse DEN 400 24 0.0070
one utilizes the total rat liver, which is
much bigger than the mouse liver, whereas
in the microsomal system the same amount
of liver from both mice and rats was used.
Mouse Strains
In evaluation of the safety of chemicals
for the human population an everpresent
dilemma is the selection of the proper mam-
malian species and within the species the
strain. As noted previously in the introduc-
tion, great differences exist between rats
and mice. Table 8 gives the comparison be-
tween mouse strains C57BL/6, DBA2/J, and
the hybrid of the two strains, B6D2F1.
Strain C57BL/6 has lower activity than
DBA2/J, which has the same activity as the
Fl hybrid between the two strains. Table 9
gives similar results obtained with another
Table 8. Variation among mouse strains in the
metabolism of DMN to a mutagen.6
Reversions
per 10 6
Mouse strain DMN, mM survivors
C57B1/6 180 19
DBA 2/J 180 38
B6D2F1 (hybrid) 180 35
" Three animals of each strain, which had been
housed and fed under similar conditions for at least
2 weeks and who were matched for age, were pooled
to determine each mutant frequency. Livers were
homogenized in 2.5 ml solution/liver, and equal
amounts of 20,000g supernatant were incubated with
180 mM, DMN, 4 mg TPNH, and Salmonella typhi-
murium for 20 min.
Table 9. Variation among mouse strains in ability
to metabolize DMN and DEN to a mutagen.6
Reversions
Com- Promutagen, per 106
Mouse strain pound mM survivors
C3H DMN 90 41
(Oak Ridge)
DBA 2/J DMN 90 10
B6C3F1 DMN 90 15
DBA 2/J - 0 0.02
C3H DEN 200 0.60
DBA 2/J DEN 200 0.51
B6C3F1 DEN 200 0.56
a Pools of three mice from each strain were used.
The livers were homogenized in 4 ml/gm liver of
buffered solution and centrifuged at 20,000g. The
supernatant was incubated 20 min with Salmonella
G46, 4 mg TPNH, and the promutagen.
series of strains and a hybrid. It is clear
from these data that C3H (Oak Ridge) has
a considerably higher activity than the hy-
brid B6C3F1, and this is in strong contrast
to the previous table where the hybri(
equaled the top strain of the cross in .
tivity. If DBA2/J can serve as basis for coni
parison, then there is an eightfold differ-
ence in activity between C3H and C57BL/6.
On the other hand, Table 9 shows clearly
that similar differences did not exist for ac-
tivation of DEN. We think these data indi-
cate the enzymes activating DMN and DEN
are different.
S. typhimurium G46 reverts after treat-
ment in the microsomal systems mixed with
DEN at a much lower rate than when mixed
with DMN. Since the mutation activity is
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sion of the specificity of the reverse muta-
tion mechanism and not a difference in
activity of the enzymes. However, in a host-
mediated assay with Neurospora as indica-
tor organism in which the conidia were in-
jected IV and recovered from the liver, the
ad 3 mutation frequency among the conidia
after DMN treatment of the animal was 500
times higher than after treatment of the
animal with DEN. Thus, the difference in
the mutagenicity of DMN and DEN are
consistent with different indicator organ-
isms, and we can conclude that the results
obtained with G46 probably are due to differ-
ence in enzyme activity and not due to spe-
cificity in reversion mechanism for active
products of these two chemicals.
In line with these observations, the data
in Table 10 shows that there is very little
increase in the reversion frequency when
the DEN concentration is varied from
25 mM to 200 mM.
Purified Microsomes and Strain Differences
A better understanding of the basis for
the strain differences and the difference be-
tween induced and noninduced animals can
be obtained by using purified microsomes.
The two most extreme mouse strains with
Table 10. Mutagenicity of DEN in various
concentrations in a microsomal preparation.'
DEN Reverse mutations
concentration, Survival, per 10
'
mM % survivors
25 79 0.51
50 95 0.32
100 68 0.60
200 52 0.81
0 100 0.15
Livers from three male B6D2F1 mice were ho-
mogenized in 2 ml of buffered solution per gram liver.
The 20,000g supernatant was incubated with 4 mg
TPNH, DEN, and Salmonella for 20 min.
respect to their ability to form mutagenic
metabolites were selected for the experi-
ment. They were C57BL/6 (the low activity
strain) and C3H (the high activity strain).
3-MC was used as an enzyme inducer. In
Table 11 the amount of purified microsomes
per gram liver is shown. It increased dra-
matically after induction by 3-MC in
C57BL/6 mice. The mutagenicity of DMN
with purified microsome was measured us-
ing the same amount of protein. It is clear
from Table 11 that in C57BL/6, mice induced
by 3-MC the same amount of purified mic-
rosomes contain a higher amount of de-
methylase activity than in noninduced
C57BL/6 mice and that in strain C3H the
Table 11. Effect of 3-methylcholanthrene enzyme induction on livers of C3H and
C57B1/6 mice in terms of microsomal protein yield, DMN demethylase activity,
and metabolism by the microsomes of DMN to a mutagen.1
Demethylase
Purified activity Reversions
Liver, mierosomes, Microsomes, nmole HCHO/ per 106
Mouse stain Inducer g mg mg/g liver mg protein-min survivors
C57B1/6 Control 4.6 40 8.7 2.66 13.8
C57B1/6 3-MC 3.9 65 16.6 4.66 42.9
C3H Control 4.9 69 14.1 3.53 20.3
C3H 3-MC 4.6 75 16.3 3.88 31.8
All mice were males matched for age and raised in the same environment for at least 2 weeks prior to
sacrifice. 3-Methylcholanthrene, 0.5 mg in 0.25 ml olive oil, was injected IP 24 hr prior to sacrifice; controls
received 0.25 ml olive oil IP. Pools of three animals were used to determine each data point. Microsomes
were prepared according to the method of Kupfer and Levin (7); protein was measured by the Lowry
technique (8). Identical 15-min incubations were done for formaldehyde production and bacterial muta-
genesis, except no bacteria were present in the demethylase assay. Incubation contained lOOmM DMN,
1.6 mg microsomal protein/ml, 1.6 mg TPNH/ml, pH 7.5 buffer, and either water or Salmonella typhimurium
in 0.9% saline.
December 1973 79demethylase activity per milligram protein
is almost the same.
Another question raised is the correlation
between mutagenic activity and demethy-
lase activity when different strains are con-
sidered and they are induced with 3-MC.
By plotting in the data obtained from under
these various conditions on the curve de-
scribing the relationship between demethy-
lase activity and reversion frequency (Fig.
3), a very good agreement was demonstr-
ated between demethylase and reversion fre-
quency independent of the variation with
respect to strain and to induction with 3-
MC.
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FIGURE 3. Correlation of microsomal DMN dem-
ethylase activity and microsome metabolism of
DMN to a mutagen. Two related strains of mice
with and without 3-methylcholanthrene enzyme
induction. This figure is an illustration of data
from Table 11.
It is interesting to note that the mouse
strain with the lowest basic demethylase ac-
tivity is the strain which is most inducible,
and when both are induced, this relationship
between strains in terms of demethylase ac-
tivity is reversed.
Discussion
Both DMN and DEN require metabolic
conversion before becoming mutagenic. Both
compounds probably form highly labile ac-
tive intermediates. The degree of reaction
with DNA is likely to depend on the pres-
ence of activating enzymes. After treat-
ment of an animal with DMN, the DNA of
the various tissues are alkylated to greatly
different degrees. The testes are among or-
gans alkylated the least. After treatment of
mice with MMS or DMN in equal doses
the amount of alkylation measured as
7-methylguanine in the DNA of the tes-
tis is, respectively, 0.05% and 0.0007%o
(4). It seems unlikely, therefore, that DMN
will give any detectable increase in the mu-
tation frequency of the male germinal cells.
Why then study the mutagenesis of DMN
at all?
The design of most experiments to study
chemical mutagenesis in mammals involves
acute or subacute treatments of the mam-
mal. We have no data which would tell us
whether there is an accumulation of point
mutations during chronic administration of
chemical mutagens to mammals. This is,
however, the most prevalent situation for
exposure of man to chemicals. One of the
important questions in extrapolating the
test data to man is: What relationship is
there between the genetic effects of approxi-
mately 30 years exposure of man to low
concentrations of a certain chemical and.
the mutation data obtained after acute
treatment of a mammal with the same chem-
ical?
Ideally, we may want to base the safety
evaluation of a compound on mutation sys-
temns based on detection of germinal muta-
tions in vivo in mammals. The question
would then be: Does that compound give a
significant increase in the frequency of mu-
Environmental Health Perspectives 80tations? As mentioned earlier, it is unlikely
that DMN would give any detectable in-
crease in the number of germinal mutations
when the testing is carried out in the stan-
dard way. Maybe therefore, in the safety eva-
luation of a chemical, it would be prefer-
able to take a more conservative posture and
base the evaluation on seeking an answer to
the following question: Can the mammal
convert the chemical under test to a muta-
genic metabolite? If so, there is reason for
caution. It is in the attempt to answer the
question that the host-mediated assay and
the microsomal system are potentially most
useful.
In assessment of the mutagenicity of en-
vironmental compounds it is important that
the test system is as relevant to man as pos-
sible. The liver microsome system, with the
use of human liver microsomes and human
cells, represents such a possibility. Most
pharmacologists, however, would agree that
the liver microsomal system can give false
negative results due to lack of, for instance,
the right coenzyme or other conditions
which are required for the biochemical re-
actions to proceed.
Summary
In summary, we have explored a number
of factors related to mammalian activation
of promutagens. We define DMN and DEN
as promutagens needing mammalian meta-
bolism to form highly mutagenic products.
For DMN the activation is microsomal,
needs some cofactors, and the mutagenic ac-
tivity of the product is directly correlated
with the metabolie formation of formalde-
hyde with and without induction and across
strains of- mice. Formaldehyde does not con-
tribute to the mutagenic activity of the reac-
tion products.
Selection of a mammalian metabolizer of
promutagens should be made with the vari-
ability between species and strains in mind.
Induction of* microsomes may increase sen-
sitivity in a given strain.
At lea t.with N-and, DEN, Salmonella
G46 is-far more. sensitive than Neurospora
as an indicatox;-.organism.
Finally, the proximity of the indicator
organism to the major site of metabolism
is related to mutagenic activity in terms of
orders of magnitude. The microsomal as-
say is a few orders of magnitude more sen-
sitive than the IP host-mediated assay, and
the intrahepatic host-mediated assay is a
few orders of magnitude more sensitive than
the in vitro microsomal system.
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